Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,012 | 59 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $259.54 | 10 | $0 (2017) |
| Depomed, Inc. | $118.66 | 5 | $0 (2017) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $78.18 | 6 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $77.27 | 6 | $0 (2018) |
| GlaxoSmithKline, LLC. | $54.59 | 3 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $54.05 | 4 | $0 (2017) |
| Valeant Pharmaceuticals North America LLC | $51.87 | 3 | $0 (2017) |
| Avanir Pharmaceuticals, Inc. | $46.67 | 3 | $0 (2017) |
| Lundbeck LLC | $43.18 | 3 | $0 (2017) |
| Lilly USA, LLC | $27.81 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $16.20 | 1 | AbbVie, Inc. ($16.20) |
| 2018 | $88.93 | 6 | Regeneron Healthcare Solutions, Inc. ($18.08) |
| 2017 | $906.57 | 52 | Allergan Inc. ($259.54) |
All Payment Transactions
59 individual payment records from CMS Open Payments — Page 3 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/07/2017 | Allergan Inc. | NAMZARIC (Drug) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: NEUROSCIENCE | ||||||
| 03/07/2017 | GENZYME CORPORATION | AUBAGIO (Drug) | Food and Beverage | In-kind items and services | $12.09 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 03/03/2017 | Allergan Inc. | NAMZARIC (Drug) | Food and Beverage | In-kind items and services | $126.71 | General |
| Category: NEUROSCIENCE | ||||||
| 03/01/2017 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: RESPIRATORY | ||||||
| 02/27/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.04 | General |
| Category: Cardiovascular | ||||||
| 02/23/2017 | Allergan Inc. | LINZESS (Drug), VIBERZI | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/22/2017 | Valeant Pharmaceuticals North America LLC | RELISTOR ORAL (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/21/2017 | Biogen, Inc. | TECFIDERA (Drug) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: NEUROLOGY | ||||||
| 01/17/2017 | Lilly USA, LLC | TRADJENTA (Drug), TRULICITY, BASAGLAR | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: Diabetes | ||||||
About Dr. Clarence Washington, M.D
Dr. Clarence Washington, M.D is a Neurology healthcare provider based in Kennewick, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1912942053.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Clarence Washington, M.D has received a total of $1,012 in payments from pharmaceutical and medical device companies, with $16.20 received in 2019. These payments were reported across 59 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($1,012).
Practice Information
- Specialty Neurology
- Location Kennewick, WA
- Active Since 06/20/2006
- Last Updated 07/21/2022
- Taxonomy Code 2084N0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1912942053
Products in Payments
- NAMZARIC (Drug) $204.08
- Nucynta (Drug) $118.66
- XARELTO (Drug) $77.27
- ELIQUIS (Drug) $54.05
- JARDIANCE (Drug) $52.88
- RELISTOR ORAL (Drug) $48.24
- NUEDEXTA (Drug) $46.67
- NORTHERA (Drug) $43.18
- TRADJENTA (Drug) $40.96
- LINZESS (Drug) $35.96
- ANORO (Drug) $21.63
- PRALUENT ALIROCUMAB INJECTION (Biological) $18.08
- BREO (Drug) $16.79
- XIFAXAN (Drug) $16.66
- NAMENDA XR (Drug) $16.29
- Synthroid (Drug) $16.20
- TRELEGY ELLIPTA (Drug) $16.17
- INJECTAFER (Drug) $15.76
- TECFIDERA (Drug) $15.75
- LYRICA (Drug) $14.99
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.